vasoregress
common
phenomenon
underli
physiolog
vessel
develop
well
patholog
microvascular
diseas
lead
peripher
neuropathi
nephropathi
vascular
oculopathi
review
describ
hallmark
pathway
vasoregress
argu
parallel
characterist
featur
vasoregress
ocular
microvessel
atherosclerosi
larger
vessel
share
molecular
pathway
molecular
effector
two
condit
outlin
thu
highlight
possibl
system
caus
local
vascular
diseas
review
give
us
systemwid
insight
factor
lead
multipl
synchron
vascular
diseas
share
molecular
pathway
might
use
address
diagnost
therapeut
need
multipl
common
complex
diseas
literatur
analysi
present
broad
interest
readership
integr
biolog
ration
drug
develop
system
medicin
v
ascular
research
epicent
integr
biolog
scholarship
black
wang
part
cardiovascular
system
transport
oxygen
blood
away
heart
aorta
left
ventricl
deliv
bodi
tissu
term
system
circul
oxygen
blood
system
circul
also
remov
carbon
dioxid
toxic
wast
tissu
return
right
atrium
heart
system
circul
two
type
macrocircul
microcircul
macrocircul
compris
arteri
vein
circul
blood
organ
arteri
enter
organ
branch
repeatedli
becom
arteriol
releas
blood
capillari
venul
collect
blood
capillari
gradual
coalesc
larger
vein
microcircul
compos
arteriol
capillari
venul
suppli
drain
capillari
blood
thinwal
capillari
respons
exchang
materi
blood
interstiti
fluid
guyton
hall
microvasculatur
constitut
import
interfac
deliveri
nutrient
remov
toxic
wast
exchang
across
vessel
wall
fluid
economi
adequ
microvascular
perfus
necessari
cell
surviv
gate
et
al
vasoregress
phenomenon
progress
obliter
capillari
repres
first
crucial
step
develop
microvascular
complic
play
promin
role
microvascular
diseas
central
peripher
nervou
system
moran
spite
regard
earli
event
variou
human
vascular
patholog
underli
mechan
vasoregress
still
wellelucid
suffici
understand
vasoregress
phenomena
may
enabl
pharmaceut
intervent
subsequ
treatment
multipl
vascular
patholog
remark
vessel
atherosclerosi
glomerular
nephropathi
diabet
retinopathi
dr
possess
compar
featur
gerald
et
al
system
biolog
studi
show
vasoregress
ocular
vessel
may
also
induc
system
vascular
diseas
atherosclerosi
gupta
et
al
macrovascular
cardiovascular
function
correl
progress
certain
eye
diseas
risk
factor
macrovascular
diseas
arteriosclerosi
includ
dyslipidemia
diabet
system
hypertens
risk
factor
import
retin
arteri
vein
occlus
retinopathi
macular
degener
local
hypoxia
increas
intraocular
pressur
dysregul
ocular
blood
flow
barrier
dysfunct
eye
link
chang
system
macrovascular
function
flammer
et
al
eye
thu
distinctli
suit
studi
microvascular
diseas
due
macrovascular
chang
review
discuss
characterist
vasoregress
special
refer
retin
microvascular
diseas
studi
extens
outlin
factor
modul
regress
pathway
involv
develop
vasoregress
lastli
note
characterist
pathway
molecular
effector
similar
atherosclerosi
present
develop
vasoregress
thu
indic
effect
macrovascular
diseas
peripher
microangipathi
share
molecular
pathway
might
address
diagnost
therapeut
need
multipl
common
complex
diseas
gome
et
al
keskin
et
al
reddi
et
al
analysi
present
broad
interest
readership
integr
biolog
macrovascular
diseas
affect
larg
blood
vessel
hyperlipidemia
sedentari
lifestyl
genet
predisposit
associ
macrovascular
diseas
atherosclerosi
main
pathogen
mechan
macrovascular
diseas
character
deposit
cholesterol
infiltr
macrophag
endothelium
larg
vessel
result
atherosclerot
plaqu
deposit
narrow
vessel
critic
point
local
coagul
embol
caus
distal
ischemia
due
vascular
occlus
atherosclerosi
sever
effect
includ
ischem
heart
diseas
coronari
arteri
diseas
carotid
arteri
diseas
myocardi
infarct
cerebrovascular
diseas
stroke
peripher
arteri
diseas
guyton
hall
kim
et
al
diabet
associ
macrovascular
microvascular
diseas
affect
sever
organ
growth
atherosclerot
plaqu
occur
mani
year
may
remain
silent
long
period
clinic
manifest
atherosclerosi
depend
vascular
bed
affect
coronari
arteri
atherosclerosi
caus
myocardi
infarct
angina
pectori
atherosclerosi
occur
vessel
suppli
central
nervou
system
frequent
caus
stroke
transient
cerebr
ischemia
peripher
circul
atherosclerosi
caus
claudic
gangren
decreas
limb
viabil
kidney
atherosclerosi
direct
effect
lead
renal
arteri
stenosi
altern
kidney
common
site
atheroembol
diseas
clinic
manifest
atherosclerosi
may
chronic
eg
effort
induc
angina
pectori
acut
myocardi
infarct
stroke
sudden
cardiac
death
libbi
microvascular
diseas
affect
small
blood
vessel
pathophysiolog
biomolecular
chang
microvasculatur
respons
caus
end
organ
damag
associ
age
mitchel
neurodegener
brown
thore
microvascular
diseas
often
associ
hypertens
hyperglycemia
hypertensioninduc
chang
microvasculatur
may
also
caus
endorgan
damag
retina
kidney
heart
brain
highli
perfus
organ
low
vascular
resist
retina
kidney
heart
brain
feihl
et
al
clinic
stage
diabet
microangiopathi
affect
differ
tissu
review
et
al
diabet
microvascular
diseas
lead
complic
diabet
retinopathi
dr
nephropathi
neuropathi
kim
et
al
cerebr
microvascular
diseas
associ
cognit
motor
impair
elderli
van
norden
et
al
microvascular
coronari
diseas
patient
show
myocardi
ischemia
without
evid
obstruct
coronari
diseas
bairey
merz
et
al
microvascular
coronari
diseas
affect
midlif
women
khuddu
et
al
correl
occurr
atherosclerosi
increas
advers
cardiac
event
von
mere
et
al
pepin
et
al
characterist
featur
dr
microaneurysm
endotheli
damag
vascular
occlus
increas
vascular
permeabl
retin
vessel
sever
dr
may
lead
aberr
neovascular
observ
prolif
retinopathi
progress
vasoregress
accompani
increas
vascular
permeabl
also
caus
increas
retin
thick
edema
macular
region
retina
chang
retin
blood
vessel
may
caus
bleed
leak
thu
distort
vision
cataract
cloud
len
eye
glaucoma
damag
optic
nerv
may
also
occur
symptom
dr
go
unnot
long
time
float
spot
appear
vision
due
leakag
abnorm
blood
vessel
may
clear
howev
recurr
bleed
caus
perman
vision
loss
macular
edema
caus
blur
vision
routin
visual
acuiti
test
confirm
eyesight
tonometri
use
check
normalci
intraocular
pressur
examin
dilat
pupil
help
check
retina
optic
nerv
patholog
chang
eye
may
reflect
blood
vessel
abnorm
chang
len
swell
macula
damag
nervou
tissu
optic
coher
tomographi
captur
detail
imag
eye
tissu
use
light
fluorescein
angiogram
use
obtain
pictur
eye
microvessel
use
fluoresc
dye
inject
blood
stream
nei
neuropathi
refer
damag
peripher
nervou
system
accompani
diabet
may
also
caus
uremia
alcohol
modifi
risk
factor
neuropathi
includ
obes
hyperlipidemia
hypertens
patient
typic
experi
pain
tingl
numb
distal
limb
sensat
numb
may
induc
loss
balanc
fall
sever
neuropathi
associ
incid
foot
ulcer
amput
lower
extrem
callaghan
et
al
distal
neuropathi
common
confirm
combin
medic
histori
foot
exam
loss
sensat
feet
loss
achil
tendon
reflex
confirm
nerv
conduct
biopsi
studi
autonom
neuropathi
involv
organ
system
caus
increas
mortal
rate
screen
use
appropri
diagnost
test
boulton
et
al
cerebr
small
vessel
diseas
group
diseas
affect
small
arteri
arteriol
venul
capillari
brain
typifi
cognit
impair
vascular
dementia
baker
et
al
van
norden
et
al
diabet
face
higher
risk
occurr
cerebrovascular
diseas
due
condit
disrupt
blood
suppli
brain
nh
addit
contribut
caus
cerebrovascular
diseas
stroke
hypertens
interrupt
blood
suppli
brain
caus
local
ischemia
death
neural
tissu
transient
ischem
attack
temporari
disrupt
blood
suppli
part
brain
subarachnoid
hemorrhag
vascular
dementia
nh
clinic
diagnost
techniqu
cerebrovascular
diseas
includ
neuropsycholog
test
magnet
reson
imag
comput
tomographi
singl
photon
emiss
comput
tomographi
positron
emiss
tomographi
baker
et
al
progress
kidney
diseas
character
damag
glomeruli
kidney
associ
atherosclerosi
diabet
metabol
disord
hypertens
obes
dyslipidemia
increas
oxid
stress
inflamm
may
mediat
initi
effect
factor
kidney
progress
deterior
renal
function
may
caus
dyslipidemia
accumul
toxin
proinflammatori
well
fibrogen
factor
lead
endotheli
cell
ec
dysfunct
atherogen
factor
play
direct
role
silent
phase
overt
ischem
diseas
well
overt
ischem
nephropathi
nkf
diabet
lead
caus
chronic
kidney
diseas
lead
kidney
failur
death
symptom
diabet
kidney
diseas
includ
hypertens
swell
lower
extrem
increas
urin
declin
glomerular
filtrat
rate
nausea
vomit
weak
pallor
anemia
screen
diabet
neuropathi
may
carri
detect
albumin
spot
hour
urin
collect
elev
serum
creatinin
hypertens
nkf
blood
vessel
constitut
fundament
unit
vasoregress
phenomenon
vessel
wall
consist
two
interact
cell
type
ec
surround
mural
cell
mc
ec
form
inner
line
vessel
wall
mc
coat
outer
surfac
mc
pericyt
present
intermitt
surfac
capillari
larger
vessel
mc
repres
vascular
smooth
muscl
cell
vsmc
share
lineag
pericyt
complet
cover
outer
surfac
often
multipl
layer
gaengel
et
al
vascular
develop
involv
process
format
matur
remodel
regress
vessel
structur
newli
form
vessel
immatur
requir
stabil
specif
cell
extracellular
compon
signal
pathway
suffici
normal
interact
ec
mc
critic
variou
aspect
vessel
format
stabil
remodel
function
armulik
et
al
carmeliet
ec
immatur
cell
secret
signal
requir
migrat
prolifer
mc
also
secret
thin
layer
matrix
known
basement
membran
bm
lead
format
stabl
blood
vessel
brey
disrupt
pericyteendotheli
interact
perivascular
extracellular
matrix
ecm
compon
neural
cell
adhes
molecul
may
lead
destabil
regress
matur
blood
vessel
benjamin
et
al
brey
gerhardt
semb
hamm
et
al
regress
blood
vessel
may
also
occur
initi
network
vessel
form
need
remodel
final
differenti
form
process
requir
apoptosi
ec
remov
excess
blood
vessel
regress
darland
damor
thu
prevent
ec
apoptosi
provid
suffici
growth
factor
may
also
prevent
vasoregress
dimmel
zeiher
integr
tight
mechan
strength
endothelium
maintain
junction
structur
also
provid
barrier
molecular
transport
carmeliet
vessel
sprout
junction
partial
compromis
accommod
increas
vessel
permeabl
reestablish
vessel
stabil
dejana
molecul
endotheli
junction
form
multiprotein
complex
growth
factor
help
regul
vessel
stabil
control
ec
respons
lampugnani
junction
complex
also
envisag
therapeut
target
revers
regress
blood
vessel
therefor
vessel
regress
may
caus
insuffici
stimulu
vessel
format
lead
failur
stabil
vascular
structur
b
ec
apoptosi
loss
essenti
growth
factor
process
remodel
vessel
lead
tissuespecif
matur
brey
c
factor
inflamm
lead
pericyt
loss
either
apoptosi
migrat
armulik
et
al
patholog
disrupt
junction
structur
endothelium
retin
vasculatur
vasoregress
result
capillari
occlus
degener
larg
number
capillari
ultim
caus
decreas
retin
perfus
aiello
et
al
robinson
et
al
turn
retin
capillari
occlus
may
either
outcom
blockag
vascular
lumen
white
blood
cell
platelet
b
death
capillari
cell
induc
biochem
abnorm
within
vascular
cell
c
death
capillari
cell
due
product
gener
nearbi
cell
like
neuron
glia
kern
eye
retin
capillari
highest
densiti
pericyt
recent
studi
establish
loss
pericyt
either
migrat
apoptosi
mark
initi
process
vasoregress
porta
lack
pericyt
protect
make
endothelium
suscept
prone
damag
armulik
et
al
hamm
et
al
pfister
et
al
porta
romeo
et
al
suggest
death
photoreceptor
cell
due
apoptosi
cell
inner
nuclear
layer
preced
vasoregress
accompani
upregul
certain
neurotrophin
like
nerv
growth
factor
ngf
ciliari
neutroph
factor
cntf
feng
et
al
upregul
inflammatori
cytokin
growth
factor
also
associ
retin
vessel
regress
junction
disrupt
lead
breakdown
bloodretin
barrier
brb
also
accompani
earli
retin
vessel
regress
eye
endotheli
damag
caus
brb
breakdown
subsequ
retin
edema
extravas
lipid
protein
fluid
caus
ocular
defect
dr
pfister
diabet
vasculopathi
devast
complic
diabet
typifi
rapid
develop
atherosclerosi
multipl
distal
site
vasoregress
due
deplet
endotheli
progenitor
cell
epc
diabet
may
also
lead
poor
collater
late
event
lead
clinic
manifest
limb
ischemia
peripher
arteri
diseas
waltenberg
similarli
tumor
format
requir
vasoregress
neoangiogenesi
newli
form
cell
mass
protein
mediat
destabil
blood
vessel
potenti
target
antiangiogen
tumor
treatment
gerald
et
al
thu
vasoregress
import
step
lead
numer
patholog
within
vascular
subunit
phenotyp
vasoregress
character
morpholog
format
acellular
capillari
retina
human
experiment
diabet
rat
format
acellular
capillari
skelet
muscl
neck
calf
foot
diabet
subject
observ
diabet
subject
often
accompani
pericyt
loss
bm
thicken
occurr
characterist
featur
skelet
muscl
may
due
underli
peripher
neuropathi
diabet
suggest
common
pathophysiolog
mechan
retin
microvessel
tilton
et
al
addit
characterist
featur
vasoregress
name
loss
mural
cell
mc
endotheli
damag
due
macrovascular
diseas
atherosclerosi
ocular
microangiopathi
detail
atherosclerosi
prolifer
migrat
apoptosi
vsmc
vital
lesion
format
vascular
remodel
plaqu
format
ruptur
lim
park
rudijanto
normal
blood
vessel
vsmc
occur
quiescent
differenti
contractil
phenotyp
regul
blood
flow
vessel
diamet
owen
schaper
ito
wolf
et
al
wherea
atherosclerot
condit
revers
phenotyp
shift
take
place
result
synthet
noncontractil
dedifferenti
vsmc
migrat
media
intima
prolifer
intim
region
stegemann
et
al
vsmc
migrat
form
indispens
part
patholog
condit
regul
variou
growth
promot
inhibitor
matrix
metalloproteinas
plateletderiv
growth
factor
pdgf
schachter
schwartz
recent
studi
atherosclerosi
highlight
role
vsmc
propag
inflamm
plaqu
form
vsmc
also
stabil
atherosclerot
plaqu
synthesi
ecm
molecul
howev
case
inflamm
injuri
activ
inflammatori
immun
cell
plaqu
lead
vsmc
apoptosi
geng
libbi
predomin
vsmc
apoptosi
prolifer
atherosclerot
state
instrument
caus
plaqu
ruptur
bennett
newbi
et
al
thu
vsmc
particip
atherosclerot
lesion
growth
also
respons
plaqu
ruptur
rudijanto
microvessel
perivascular
pericyt
possess
contractil
fiber
wrap
around
ec
capillari
venul
throughout
bodi
pericyt
consist
cell
bodi
nucleu
cytoplasm
embrac
endotheli
wall
function
pericyt
fulli
understood
found
regul
microvascular
diamet
blood
flow
kutcher
herman
peppiatt
et
al
pericyt
besid
key
compon
neurovascular
unit
also
serv
varieti
import
function
provid
vascular
stabil
matur
develop
vasculatur
control
ec
prolifer
regul
capillari
blood
flow
pericyt
also
involv
mainten
clearanc
phagocytosi
cellular
debri
mainten
bloodbrain
barrier
permeabl
mediat
physiolog
patholog
repair
process
ocular
vessel
pericyt
stabil
vessel
protect
vasoregress
jyothi
role
pericyt
vasoregress
highlight
loss
much
prior
develop
acellular
capillari
hamm
pericyt
also
manifest
crosstalk
system
inflamm
sever
vascular
disord
yet
contradictori
report
show
abund
pericyt
retin
capillari
guarante
vascular
stabil
retin
microvasculatur
vessel
may
still
regress
brey
et
al
thu
role
pericyt
associ
factor
format
matur
stabl
microcircul
requir
elucid
sever
mechan
propos
explain
pericyt
loss
accompani
vasoregress
pericyt
apoptosi
occur
earli
day
induct
diabet
anim
model
consid
one
initi
vasoregress
lead
complic
eye
li
et
al
loss
pericyt
attribut
endotheli
hyperplasia
increas
capillari
diamet
abnorm
shapestructur
ec
modifiedirregular
shape
protein
alter
junction
protein
distribut
lead
activ
proapoptot
pathway
curti
et
al
hamm
et
al
hamm
stirban
et
al
b
pericyt
migrat
transloc
pericyt
one
alloc
posit
capillari
anoth
recent
studi
show
number
pericyt
lost
larg
exce
number
pericyt
lost
apoptosi
indic
particip
addit
mechan
like
pericyt
migrat
pfister
et
al
howev
quantit
contribut
pericyt
migrat
pericyt
loss
destini
transloc
pericyt
remain
elucid
thu
migrat
alter
rest
quiescient
phase
share
featur
atherosclerosi
dr
howev
tissuespecif
respons
mc
larg
vessel
prolifer
dr
mark
apoptosismigr
endotheli
cell
ec
line
inner
surfac
blood
vessel
system
endotheli
damag
result
cluster
diseas
atherosclerosi
coronari
heart
diseas
endotheli
damag
disrupt
balanc
vasoconstrict
vasodil
initi
plethora
event
endotheli
permeabl
platelet
aggreg
leukocyt
adhes
result
atherosclerosi
davignon
ganz
endotheli
damag
induc
state
accompani
reduc
nitric
oxid
bioavail
provasoconstrict
prooxid
stress
proinflamm
result
atherosclerot
plaqu
format
sequela
mudau
et
al
thu
constitut
initi
revers
step
atherosclerot
develop
earli
clinic
identif
damag
endothelium
may
becom
import
tool
prognosi
atherosclerosi
mudau
et
al
microvessel
eye
sever
studi
anim
model
demonstr
clearli
pericyt
disappear
much
ec
start
vanish
hamm
et
al
pericyt
dropout
conceiv
primari
step
endothelium
reactiv
reduc
endotheli
protect
recent
studi
transgen
rat
suggest
neuron
dysfunct
glial
chang
occur
prior
vasoregress
develop
dr
endothelium
along
junction
protein
occludin
claudin
zona
occluden
protein
compris
function
part
brb
endotheli
damag
may
caus
brb
breakdown
lead
increas
permeabl
seepag
lipid
protein
fluid
extracellular
space
jyothi
ultim
lead
variou
ocular
complic
blur
vision
macula
swell
brb
breakdown
occur
secondari
alter
tight
junction
pericyt
loss
ec
loss
increas
vesicular
transport
membran
permeabl
thu
pericyt
migrat
apoptosi
initi
vasoregress
follow
subsequ
degener
ec
make
remain
vasculatur
vulner
destruct
signal
fig
inflamm
immunovascular
respons
harm
stimuli
infect
stress
injuri
via
trigger
correspond
inflammatori
cascad
may
involv
sever
immun
cell
blood
vessel
molecular
mediat
becom
clear
recent
year
acut
chronic
inflammatori
event
associ
critic
vascular
remodel
atherosclerosi
aihara
et
al
inflamm
known
particip
endotheli
desquam
hallmark
atherosclerosi
local
product
inflammatori
mediat
oxid
lipoprotein
libbi
inflammatori
mediat
turn
activ
matrix
metalloproteinas
degrad
subendotheli
bm
rajavashisth
et
al
inflammatori
stimul
may
also
promot
ec
produc
enzym
degrad
ecm
constitu
adher
normal
circumst
libbi
inflamm
also
play
vital
role
plaqu
disrupt
ruptur
libbi
vivo
studi
patient
inflammatori
arthriti
show
inflamm
lead
immatur
unstabl
vessel
pericyt
recruit
thu
disrupt
pericyteec
crosstalk
kennedi
et
al
link
inflamm
retin
vasoregress
crucial
multifacet
inflamm
eye
vasculatur
induc
high
level
certain
inflammatori
cytokin
mediat
may
result
sever
microvascular
patholog
calong
et
al
mccluskey
powel
wakefield
lloyd
addit
system
inflamm
lead
ocular
manifest
mani
diseas
mccluskey
powel
mohsenin
huang
proinflammatori
protein
fig
cartoon
schemat
illustr
mechan
vessel
regress
associ
atherosclerosi
macrovascular
patholog
ocular
vasculopathi
microvascular
diseas
inflammatori
andor
stress
condit
blood
vessel
may
lose
mural
cell
mc
coverag
either
due
migrat
apoptosi
normal
condit
homeostat
repair
occur
due
presenc
variou
growth
factor
surviv
factor
contrari
sustain
inflammatori
microenviron
mc
loss
serv
preced
disrupt
ecmc
interact
result
degrad
strip
ec
basal
membran
due
particip
variou
signal
pathway
vascular
permeabl
get
alter
result
exud
protein
lipid
fluid
ecm
caus
vasculopathi
macroand
microvasculatur
activ
nfjb
also
lead
cell
damag
death
retin
tissu
kern
rathnasami
et
al
yoshida
et
al
brb
breakdown
critic
event
occurr
vessel
regress
also
consequ
inflamm
occhiutto
et
al
vinor
et
al
low
densiti
lipoprotein
ldl
get
oxid
oxid
ldl
oxldl
result
alter
properti
make
oxldl
appear
foreign
immun
system
oxldl
proatherogen
mark
initi
develop
atherosclerot
plaqu
follow
leukocyt
attract
intima
ingest
lipid
leukocyt
differenti
foam
cell
well
prolifer
leukocyt
smc
ec
dokken
recent
studi
confirm
role
oxldl
increas
reactiv
oxygen
speci
ro
gener
ec
activ
dysfunct
macrophag
foam
cell
format
smc
migrat
prolifer
lead
vascular
complic
like
atherosclerosi
pirillo
et
al
vasoregress
diabet
retina
may
also
result
hyperglycemiainduc
modif
level
andor
chemic
makeup
lipid
fatti
acidbas
hormon
blood
two
main
type
modif
report
name
posttransl
modif
lipoprotein
chang
biosynthesi
eicosanoid
chew
et
al
keech
et
al
lyon
et
al
elev
serum
lipid
level
associ
increas
risk
ocular
problem
like
dr
loss
vision
idiculla
et
al
oxldl
also
mediat
capillari
injuri
dr
zhang
et
al
previou
studi
bovin
retin
capillari
ec
well
establish
impact
modifi
oxldl
retin
pericyt
contribut
earli
dr
li
et
al
lyon
et
al
zhang
et
al
increas
proinflammatori
eicosanoid
deriv
eicoanoid
combin
decreas
antiinflammatori
unsatur
fatti
acid
diabet
retina
implic
develop
vasoregress
neovascular
tikhonenko
et
al
role
hyperlipidem
state
atherosclerosi
kanter
et
al
frequent
occurr
diabet
taken
togeth
role
pathogenesi
dr
also
establish
clear
link
develop
ocular
microangiopathi
cardiovascular
diseas
cvd
hyperlipidemiainduc
prematur
vessel
atherosclerosi
also
lead
hyperlipidem
vascular
lesion
lipid
infiltr
retina
disord
lipemia
retinali
rymarz
et
al
leukostasi
attract
adhes
leukocyt
vascular
wall
fatal
complic
character
abnorm
aggreg
leukocyt
vascular
tissu
seen
white
cell
plug
microvasculatur
acut
condit
caus
occlud
circul
lead
complic
headach
chronic
ischemia
cerebrovascular
incid
ocular
accid
even
death
atherogenesi
cholesterolladen
molecul
blood
stream
infiltr
arteri
wall
prompt
express
leukocyt
adhes
molecul
endothelium
result
aggrav
atherosclerosi
mesta
ley
vanderlaan
reardon
atherogen
diet
trigger
express
vascular
cell
adhes
molecul
lead
attach
circul
monocy
leukocyt
cybulski
gimbron
li
et
al
leukostasi
retin
capillari
also
caus
nonperfus
death
retin
ec
kern
adher
leukocyt
diabet
endothelium
retin
vasculatur
obstruct
capillari
due
larg
cell
volum
high
rigid
leukocyt
leukostasi
also
lead
ec
apoptosi
via
fasl
retin
vasculatur
joussen
et
al
inhibit
nfjb
block
hyperglycemiainduc
product
inflammatori
molecul
ocular
tissu
attenu
leukostasi
miyamoto
et
al
zhang
et
al
leukostasi
prevent
block
genet
elimin
intracellular
adhes
adami
joussen
et
al
high
dose
antiinflammatori
agent
reduc
leukostasi
ec
death
suppress
brb
breakdown
diabet
rat
joussen
et
al
event
lead
format
acellular
capillari
eye
due
leukostasi
propos
lutti
increas
level
leukocyt
ec
b
bind
neutrophil
caus
express
c
oxid
burst
bound
polymorphonuclear
lymphocyt
pmn
injur
ec
caus
loss
bound
pmn
occlud
capillari
lead
local
ischemia
reperfus
e
loss
ec
expos
bm
caus
format
plateletfibrin
thrombu
f
loss
pericyt
format
acellular
capillari
thu
leukostasi
inher
characterist
inflamm
driven
chang
macroand
microvasculatur
epc
circul
cell
bone
marrow
enter
bloodstream
travel
injur
blood
vessel
repair
damag
thu
strengthen
integr
vascular
endothelium
inher
requir
vessel
homeostasi
format
stabil
matur
epc
abil
differenti
ec
also
involv
endotheli
homeostasi
format
new
vasculatur
endothelium
play
role
protect
inflamm
thrombosi
cvd
yang
et
al
atherosclerosi
reduc
number
dysfunct
epc
observ
epcbas
therapi
propos
improv
vascular
structur
function
treatment
atherosclerosi
du
et
al
cytometr
studi
demonstr
deplet
epc
may
lead
endotheli
dysfunct
mark
initi
event
pathogenesi
atherosclerosi
epc
also
involv
repair
damag
line
blood
vessel
angiogenesi
injuri
shantsila
et
al
dysfunct
exhaust
epc
bloodstream
may
addit
caus
vascular
diseas
age
coronari
arteri
diseas
hypercholesterolemia
level
circul
epc
also
use
surrog
index
marker
occurr
atherosclerosi
cvd
present
factor
respons
modul
number
characterist
circul
epc
investig
dr
alter
number
function
epc
interpret
level
type
epc
report
clinic
condit
remain
inconclus
howev
specif
epc
subtyp
may
import
diseas
prognosi
stratif
therapeut
treatment
diabet
prolif
dr
loi
et
al
ec
dysfunct
poor
collater
effect
epc
deplet
also
promin
earli
stage
dr
impair
function
epc
may
restor
improv
mobil
exampl
statin
vascular
endotheli
growth
factor
vegf
estrogen
drug
improv
function
lead
selfrepair
damag
capillari
diabet
retina
caballero
et
al
increas
product
advanc
glycat
endproduct
age
age
compound
form
nonenzymat
reaction
reduc
sugar
proteinslipidsnucl
acid
age
compound
diffus
cell
caus
modif
ecm
molecul
lead
cellular
dysfunct
charoni
et
al
farooqui
highli
reactiv
age
compound
also
modifi
intracellular
protein
chang
structur
crosslink
enzymat
activ
receptor
recognit
impair
clearanc
age
also
interact
specif
rage
receptor
present
cell
involv
atherosclerosi
agerag
axi
associ
trigger
oxid
stress
inflamm
apoptosi
elev
level
age
lead
heighten
advers
atherosclerot
effect
thu
also
propos
biomark
atherosclerot
lesion
diabet
subject
chang
et
al
hyperlipidem
stress
also
found
caus
upregul
receptor
age
accompani
increas
phosphoryl
akt
could
attenu
treatment
fluvastatin
drug
use
treat
cardiovascular
diseas
georgescu
popov
increas
level
age
report
retin
vessel
dr
stitt
et
al
age
modifi
circulatori
protein
bind
rage
lead
activ
downstream
pathway
like
nfjb
pathway
howev
isol
studi
demonstr
agedepend
accumul
age
vascular
bed
len
anim
model
georgescu
popov
age
induc
apoptosi
retin
pericyt
activ
transcript
factor
like
mediat
jnk
map
kinas
alikhani
et
al
curti
et
al
farooqui
stirban
et
al
moreov
inhibit
format
age
also
found
reduc
progress
dr
bhatwadekar
et
al
kern
engerman
stitt
et
al
thallasbonk
et
al
apart
proinflammatori
role
eicosanoid
increas
angiopoietin
express
either
directli
vegf
express
lead
vasoregress
guo
et
al
thu
may
postul
increas
level
age
receptor
constitut
key
factor
atherosclerosi
well
vascular
diseas
eye
process
vasoregress
vascular
permeabl
capac
blood
vessel
wall
allow
passag
molecul
vessel
alter
inflammatori
state
atherosclerosi
regard
inflammatori
disord
pervad
endotheli
dysfunct
caus
increas
permeabl
plasma
constitu
lipoprotein
ross
increas
number
vascular
permeabil
factor
eg
vegfa
histamin
caus
influx
proteinenrich
plasma
surround
tissu
chronic
vascular
hyperperm
associ
patholog
angiogenesi
found
variou
chronic
inflammatori
diseas
nagi
et
al
angiogenesi
assist
remodel
ecm
proteas
specif
inflammatori
respons
also
activ
uniqu
subtyp
special
ec
invad
tissu
perfus
repair
arroyo
iruelaarisp
microvasculatur
eye
prolong
stimuli
permeabilityinduc
agent
vegf
affect
barrier
integr
make
vessel
fragil
compound
unstabl
endotheli
junction
pericyt
insuffici
jyothi
dr
increas
leukostasi
cytokin
growth
factor
acut
inflamm
lead
increas
capillari
hydrostat
pressur
may
final
result
breakdown
brb
pfister
increas
permeabl
associ
disrupt
junction
integr
brb
form
development
basi
ocular
complic
dr
romeroaroca
accordingli
treatment
dr
aldos
reductas
inhibitor
protein
dinas
c
pkc
inhibitor
tyrosin
kinas
inhibitor
cycloxygenas
cox
inhibitor
steroid
vegf
antagonist
tnfa
receptor
antagonist
pparc
ligand
kern
aid
normal
vascular
permeabl
peripher
nervou
system
glial
schwann
cell
provid
myelin
larg
axon
clear
cellular
debri
around
neuron
nonmyelin
schwann
cell
associ
small
axon
critic
neuron
surviv
bung
satellit
cell
control
respons
extern
chemic
environ
around
neuron
hanani
schwann
cell
damag
thought
import
compon
diabetesinduc
neuropathi
ldl
receptor
relat
protein
regul
inflamm
neuron
injuri
condit
found
cooccur
atherosclerosi
schwann
cell
show
greatli
increas
express
prosurviv
tactic
respons
nerv
injuri
gonia
campana
also
show
antiatherogen
activ
vsmc
limit
pdgfb
receptor
signal
boucher
et
al
mechan
antiatherogen
activ
includ
lower
inflammatori
mediat
modul
ecm
remodel
gaultier
et
al
overton
et
al
yancey
et
al
also
control
vascular
remodel
effect
tgfb
signal
pathway
muratoglu
et
al
exist
tight
function
associ
glial
cell
retin
vasculatur
princip
glial
cell
induc
product
growth
factor
neurotrophin
inflammatori
factor
cntf
fibroblast
growth
factor
fgf
ngf
cytokin
affect
retin
vasculatur
retin
cell
stress
glial
cell
activ
occur
earli
event
vasoregress
glial
cell
includ
astrocyt
cell
becom
activ
pericyt
ec
fail
maintain
vascular
integr
result
vasoregress
glial
cell
one
hand
protect
retina
produc
heat
shock
protein
neurotrophin
aid
elimin
harm
molecul
hand
may
also
releas
inflammatori
cytokin
aggrav
blood
vessel
damag
wang
glial
cell
express
induc
vascular
cell
deplet
progress
capillari
occlus
sever
retin
patholog
photoreceptor
degener
dr
involv
microgli
activ
howev
exact
mechan
microgli
activ
lead
vasoregress
still
unclear
pfister
format
stabl
vasculatur
prevent
vessel
regress
tightli
regul
numer
signal
pathway
stabl
properli
function
vasculatur
achiev
balanc
signal
favor
vessel
stabil
factor
favor
vessel
regress
bussolino
et
al
signal
pathway
affect
vessel
stabil
regul
prolifer
apoptosi
ec
mc
signal
pathway
affect
vascular
stabil
caus
regress
discuss
complement
pathway
central
dual
role
atherosclerosi
classic
complement
pathway
may
atheroprotect
remov
cell
debri
apoptot
cell
atherosclerot
plaqu
howev
activ
altern
pathway
may
activ
proatherogen
stimuli
promot
plaqu
ruptur
speidl
et
al
evid
upregul
innat
immun
complement
cascad
member
like
system
diseas
like
atherosclerosi
enhanc
express
detect
inflammatori
vsmc
sever
compon
immun
respons
pathway
complement
cascad
tumor
necrosi
factor
receptor
superfamili
member
play
critic
role
develop
vasoregress
rat
model
complement
cascad
compon
also
express
microgli
cell
vasoregress
molecular
compon
immun
respons
complement
cascad
also
mediat
endotheli
prolifer
regul
apoptosi
well
control
prostaglandin
metabol
thu
complement
cascad
present
import
link
inflammatori
stimuli
vasoregress
shi
et
al
pdgf
famili
four
ligand
ad
secret
ec
play
critic
role
mc
neural
develop
recruit
prolifer
stabil
vascular
matur
pdgf
famili
member
exist
disulfidelink
homodim
b
isoform
also
form
heterodim
betsholtz
hoch
soriano
lindahl
et
al
observ
mc
first
induc
absenc
pdgf
pathway
fail
prolifer
grow
blood
vessel
absenc
pdgf
pathway
induct
hellstrom
et
al
atherosclerosi
pdgfb
pdgfrb
receptor
induc
prolifer
migrat
vsmc
ross
convers
retard
inhibit
pdgf
signal
sano
et
al
vivo
studi
conduct
mice
model
also
illustr
pdgfrbdefici
mice
possess
pericyt
result
hyperdil
blood
vessel
lindahl
et
al
interrupt
ecmc
interact
target
pdgfb
pathway
also
caus
vascular
destabil
abnorm
blood
vessel
remodel
benjamin
et
al
hellstrom
et
al
studi
base
diseas
model
retin
pigmentosa
reveal
pdgfcc
pdgfc
homodim
render
vasoprotect
effect
play
pivot
role
blood
vessel
mainten
surviv
moreov
mechanist
illustr
pdgf
receptor
pdgfra
pdgfrb
essenti
vasoprotect
effect
pdgfcc
retina
et
al
thu
pdgf
pathway
regul
pericyt
coverag
vascular
remodel
human
vasculatur
neurotrophin
famili
closelyrel
protein
act
surviv
signal
neuron
central
peripher
nervou
system
play
critic
role
cardiovascular
develop
mainten
neurotrophin
also
respons
surviv
ec
vsmc
regul
vasculogenesi
act
differ
receptor
neurotrophin
implic
neovascular
impair
angiogenesi
caporali
emanu
brainderiv
neurotroph
factor
bdnf
also
report
critic
ec
surviv
vessel
stabil
myocardium
donovan
et
al
late
embryon
develop
recruit
pericyt
smc
extens
pericyt
process
coverag
myocardi
vessel
depend
activ
bdnf
anastasia
et
al
neurotrophin
pathway
implic
develop
cardiac
ischemia
atherosclerosi
chaldakov
et
al
neurotrophin
essenti
growth
differenti
surviv
develop
matur
retina
deregul
growth
factor
express
neurotrophin
signal
pathway
like
cntf
fgf
ngf
lead
earli
pericyt
loss
result
initi
develop
vasoregress
process
pfister
neurotroph
factor
like
glia
deriv
neurotroph
factor
secret
glial
cell
also
regul
tight
junction
thu
modul
brb
vascular
permeabl
dr
nishikiori
et
al
upregul
express
cntf
prior
vasoregress
like
reflect
respons
photoreceptor
damag
ngf
upregul
onset
vasoregress
may
associ
microvascular
degener
pfister
imbal
ngfprongf
ratio
caus
oxid
milieu
diabet
retina
elev
level
prongf
ocular
fluid
prolif
dr
patient
rais
possibl
prongf
contribut
develop
prolif
stage
diseas
prongf
also
induc
potent
angiogen
respons
retin
ec
get
block
trka
inhibit
suggest
contribut
prongf
prolif
dr
via
activ
trka
elshaer
et
al
ngfprongf
balanc
also
report
alter
vegf
express
mechan
mutual
regul
modul
retin
vasculatur
yet
deciph
taken
togeth
studi
point
potenti
contribut
prongf
ngf
develop
dr
gupta
bhatnagar
mysona
et
al
thu
neurotrophin
signal
like
play
signific
role
human
vasculatur
involv
vessel
regress
need
elucid
receptor
tyrosin
kinas
express
ec
bind
vasoprotect
angiogen
ligand
natur
occur
homolog
ligand
antagon
activ
disrupt
blood
vessel
format
balanc
determin
function
endotheli
barrier
angiogenesi
respons
inflamm
cogan
et
al
hanahan
thurston
et
al
absenc
vegf
destabil
vessel
induc
ec
apoptosi
howev
presenc
vegf
caus
vessel
sprout
jain
role
atherosclerosi
elucid
howev
novel
atheroprotect
activ
stress
ec
activ
endotheli
nitric
oxid
synthas
prevent
ldl
oxid
ahm
et
al
angiopoietin
like
proatherogen
atheroprotect
effect
atherosclerosi
trollop
golledg
sever
studi
report
upregul
progress
vasoregress
play
import
role
coverag
vessel
pericyt
modul
respons
pericyt
loss
earli
retinopathi
pfister
system
play
critic
role
detach
migrat
pericyt
microvasculatur
lead
pericyt
loss
pfister
et
al
patholog
condit
modul
intraand
preretin
vessel
format
eye
therefor
critic
retin
neovascularis
initi
pfister
mice
manifest
deceler
agedepend
vascular
chang
retina
data
suggest
pathway
play
critic
role
regress
blood
vessel
ppar
group
nuclear
receptor
protein
avail
three
isoform
ppara
b
c
ppara
benefici
effect
vasculatur
protect
hypertens
inflamm
oxid
stress
cervantesperez
et
al
ding
et
al
hu
et
al
moran
studi
hypertens
diabet
model
illustr
pparc
regul
mapk
contribut
vascular
remodel
benkiran
et
al
ppara
c
activ
found
reduc
atherosclerosi
progress
inhibit
format
macrophag
foam
cell
ro
format
duval
et
al
neve
et
al
zandbergen
plutzki
ppara
increas
plaqu
stabil
atherosclerosi
prevent
thrombogen
pparc
activ
affect
recruit
monocyt
atherosclerot
lesion
neve
et
al
pparc
also
report
play
vital
role
pathogenesi
variou
ocular
diseas
macular
degener
amd
dr
kerat
optic
neuropathi
sever
pparc
agonist
prove
prevent
eye
diseas
corneal
scar
format
dri
eye
diseas
dr
thu
pparc
may
emerg
potenti
drug
target
treatment
atherosclerosi
well
ocular
diseas
pkc
pathway
constitu
protein
play
crucial
role
initi
pericyt
apoptosi
impair
vascular
integr
pkc
pathway
besid
regul
express
numer
vasoact
protein
also
mediat
ec
permeabl
extracellular
remodel
activ
pkc
pathway
acceler
proatherosclerot
mechan
includ
endotheli
dysfunct
nitric
oxid
synthas
no
express
vsmc
growth
migrat
apoptosi
raskmadsen
king
perturb
vascular
cell
homeostasi
caus
differ
pkc
isoform
pkca
associ
larg
vessel
atherosclerosi
cardiomyopathi
small
vessel
retinopathi
nephropathi
neuropathi
complic
gerald
king
variou
pkc
isoform
involv
pathogenesi
atherosclerosi
pkcb
increas
uptak
oxldl
thu
trigger
cascad
proatherosclerot
mechan
osto
et
al
pkcb
deplet
found
decreas
atherosclerosi
harja
et
al
pkcd
particip
smc
apoptosi
delet
isoform
led
arteriosclerosi
leitg
et
al
howev
addit
isoform
may
involv
step
atherosclerosi
activ
pkc
isoform
may
also
trigger
impair
vascular
integr
major
hallmark
initi
vasoregress
gerald
king
pfister
therefor
whether
benefici
inhibit
multipl
pkc
isoform
halt
prevent
complex
mechan
relat
atherosclerosi
remain
resolv
pkc
pathway
play
crucial
role
format
acellular
capillari
cell
apoptosi
retina
gerald
et
al
pkc
isoform
pkca
also
regul
leukocyt
adhes
apoptosi
cytokin
activ
diabet
retina
gerald
king
pkcb
isoform
inhibitor
regard
import
regul
hyperglycemiainduc
endotheli
dysfunct
yield
posit
result
clinic
trial
beckman
et
al
inhibit
pkc
earlier
stage
retinopathi
may
increas
occurr
pericyt
apoptosi
retin
capillari
pomero
et
al
hexosamin
biosynthet
pathway
help
synthesi
amino
sugar
build
block
proteinlipid
glycosyl
pathway
propos
act
nutrient
sensor
aid
develop
insulin
resist
vascular
effect
diabet
hyperglycemia
buse
plasminogen
activ
get
upregul
via
hexosamin
pkc
pathway
overexpress
promot
vsmc
mitosi
play
key
role
atherosclerosi
develop
edward
et
al
sayeski
kudlow
particip
hexosamin
pathway
vessel
regress
still
nascent
stage
need
explor
hyperglycemia
enhanc
express
certain
growth
factor
like
tgfb
thu
stimul
ecm
synthesi
via
hexosamin
pathway
high
glucos
level
also
increas
ro
product
lead
format
age
compound
accumul
microvascular
cell
activ
hexosamin
pathway
giacco
brownle
hamm
consequ
modif
critic
intraand
extracellular
protein
caus
disturb
energi
metabol
lead
retin
damag
pfister
activ
mapk
pathway
directli
attribut
oxldl
mapk
pathway
play
import
role
regul
foam
cell
format
pathogenesi
macrovascular
patholog
like
atherosclerosi
muslin
zhao
et
al
three
mapk
pathway
get
activ
ldl
perform
function
apoptosi
occurr
vascular
regress
mapk
pathway
play
pivot
role
pathogenesi
mani
vascular
diseas
get
activ
system
inflamm
environment
stress
xia
et
al
activ
mapk
pathway
regul
variou
transcript
factor
kinas
phosphoryl
lead
pericyt
apoptosi
vasoregress
downstream
activ
nfjb
pathway
gerald
et
al
also
result
sever
ocular
complic
dr
uveiti
rohilla
et
al
nfjb
wide
express
endotheli
transcript
factor
regul
key
gene
particip
inflamm
immun
respons
apoptosi
prolifer
gupta
et
al
signific
particip
transcript
factor
like
nfjb
vessel
remodel
grosjean
et
al
role
nfjb
pathway
pathogenesi
atherosclerosi
complex
depend
larg
mode
inactiv
nfjb
inactiv
macrophag
select
delet
ijb
kinas
aggrav
atherosclerosi
kanter
et
al
nfjb
inactiv
inhibit
subunit
result
attenu
atherosclerosi
kanter
et
al
studi
ldl
receptordefici
mice
confirm
inhibit
nfjb
pathway
may
affect
proand
antiinflammatori
balanc
macrophag
lead
atherosclerosi
kanter
et
al
suggest
nfjb
particip
atherosclerosi
may
due
role
macrophag
due
role
erk
signal
activ
sikorski
et
al
especi
diabet
high
glucos
level
trigger
cytokin
mediat
proinflammatori
state
caus
increas
nfjb
activ
lead
vascular
dysfunct
patel
santani
retin
nfjb
activ
earli
diabet
remain
activ
month
kowluru
et
al
studi
ocular
complic
also
indic
effect
nfjb
earli
onset
diseas
inhibit
nfjb
regul
protein
like
ino
inhibit
retin
capillari
degener
pericyt
apoptosi
nfjb
inhibitor
salicyl
reduc
express
inflammatori
mediat
thu
inhibit
capillari
degener
pericyt
loss
slow
develop
retinopathi
zheng
et
al
nfjb
get
activ
oxid
stress
lead
retin
cell
death
kowluru
koppolu
kowluru
et
al
regul
antioxid
enzym
nfjb
also
key
mediat
retin
cell
apoptosi
nfjb
signal
pathway
found
activ
ec
pericyt
hyperglycem
condit
activ
may
play
role
earli
develop
dr
kowluru
et
al
vegf
signal
play
signific
role
prolifer
differenti
permeabl
endothelium
member
vegf
famili
includ
vegf
b
c
placenta
growth
factor
vegf
critic
role
develop
normal
vasculatur
mainten
viabil
immatur
blood
vessel
facilit
pericyt
recruit
reinmuth
et
al
variou
isoform
vegf
differ
abil
bind
heparin
sulfat
possess
differenti
bioavail
may
play
distinct
role
vessel
develop
vegf
protect
ec
apoptot
cell
death
carmeliet
et
al
dimmel
zeiher
ferrara
et
al
gerber
et
al
perform
junction
stabil
murakami
vegf
also
vascular
protect
factor
due
remark
abil
increas
nitric
oxid
product
nitric
oxid
prevent
endotheli
dysfunct
inhibit
smc
prolifer
act
antiatherogen
factor
prevent
develop
atherosclerosi
libbi
murakami
blockag
vegf
signal
disrupt
pericyt
coverag
ec
caus
ec
apoptosi
gerber
et
al
gupta
et
al
lead
regress
blood
vessel
sever
studi
confirm
absenc
vegf
result
capillari
nonperfus
abnorm
vasculatur
carmeliet
et
al
dimmel
zeiher
ferrara
et
al
gerber
et
al
vegf
promot
restor
damag
endothelium
physiolog
condit
stimul
microvessel
format
insid
atherosclerot
plaqu
lead
intraplaqu
hemorrhag
tunon
et
al
antivegf
therapi
administ
system
compromis
patient
safeti
caus
cardiovascular
complic
hypertens
thrombosi
hemorrhag
tunon
et
al
thu
safeti
new
antivegf
therapi
must
care
assess
retin
hypoxia
result
format
releas
vegf
vegf
lead
neovascular
optim
therapeut
target
treatment
ocular
diseas
includ
macular
degener
dr
vascular
occlus
neovascular
glaucoma
sinha
et
al
vegfa
potent
angiogen
agent
prolong
signal
disrupt
endotheli
junction
thu
compromis
vascular
integr
therefor
antivegf
therapi
use
treatment
microvascular
diseas
agerel
macular
degener
dr
use
antivegf
agent
treatment
dr
still
investig
found
encompass
variou
side
effect
murakami
common
differ
macrovascular
diseas
microvascular
diseas
note
previou
work
cade
forb
cooper
similar
uniqu
featur
microvascular
diseas
differ
tissu
also
highlight
cade
forb
cooper
kanbay
et
al
microvascular
diseas
gupta
bhatnagar
character
vsmc
prolifer
matrix
deposit
small
arteriol
lead
narrow
lumen
may
occur
either
due
distal
ischemia
due
impair
autoregul
blood
flow
vascular
bed
number
proscleros
factor
caus
endotheli
dysfunct
vsmc
prolifer
proinflammatori
effect
induc
phenotyp
switch
vsmc
mark
increas
collagen
deposit
diminish
contractil
respons
kanbay
et
al
inflammationrel
chang
may
earli
perhap
primari
caus
target
end
organ
damag
may
also
induc
hypertens
intengan
schiffrin
suematsu
et
al
diabet
microangiopathi
share
common
etiopathogenesi
persist
hyperglycemia
lead
overactiv
multipl
pathway
oxid
stress
decreas
vasodil
increas
ecm
product
bm
thicken
enhanc
vascular
permeabl
damag
cellular
structur
function
et
al
thicken
bm
remain
one
common
structur
modif
diabet
thicken
lead
alter
vessel
function
hypertens
reduc
wound
heal
tissu
hypoxia
cade
orasanu
plutzki
addit
mechan
vascular
diseas
diabet
includ
increas
endotheli
growth
factor
product
persist
inflamm
hemodynam
dysregul
increas
platelet
activ
enhanc
fibrinolyt
capabl
cade
ensu
endotheli
damag
loss
microvessel
lead
microangiopath
disord
mani
organ
fig
genet
epigenet
immunolog
factor
modifi
clinic
present
thu
consid
import
factor
pathogenesi
villeneuv
natarajan
hypertens
anoth
major
modifi
risk
factor
stroke
small
vessel
diseas
prevent
hypertens
diminish
occurr
microvascular
cerebr
complic
atherothrombot
stroke
vascular
dementia
sierra
microvascular
ocular
complic
nephropathi
share
pathophysiolog
mechan
lead
oxid
stress
due
superoxid
product
mechan
also
involv
patholog
macrovascular
endothelium
accordingli
overexpress
enzym
superoxid
dismutas
mice
model
prevent
retinopathi
nephropathi
well
cardiac
myopathi
giacco
brownle
associ
retin
microvascular
abnorm
renal
dysfunct
suggest
similar
system
mechan
may
underli
damag
wong
et
al
diabet
neuropathi
microvascular
damag
vasa
vasorum
take
place
due
increas
oxid
stress
thornalley
inflammatori
vasculopathi
said
et
al
clinic
correl
also
shown
chronic
kidney
diseas
cvd
neurolog
disord
similar
attribut
hemodynam
similar
vascular
bed
brain
kidney
mogi
horiuchi
orourk
safar
tissuespecif
respons
microangiopathi
may
vari
eye
dysfunct
pericyt
destabil
eye
structur
leukocyt
adhes
capillari
leakag
microthrombosi
occur
progress
retinopathi
like
lead
complet
loss
vision
uncheck
kidney
glomerular
tubular
mesangi
cell
expans
seen
hyalin
connect
tissu
glomerular
capillari
chronic
kidney
diseas
may
final
lead
end
stage
renal
diseas
loss
life
et
al
imbal
sodium
potassium
channel
well
derang
product
prostaglandinsthromboxan
lead
cellular
dysfunct
cameron
et
al
activ
immun
respons
kelkar
et
al
low
nerv
growth
factor
pitteng
vinik
respons
may
also
contribut
neuropathi
thu
common
set
caus
mechan
microangiopathi
exist
even
tissuespecif
respons
may
vari
patient
histori
physic
examin
remain
mainstay
diagnost
microvascular
diseas
neuropathi
difficult
recogn
due
subclin
natur
variabl
symptom
either
sensorymotor
disturb
disturb
autonom
nervou
system
manifest
clinic
autonom
neuropathi
may
caus
symptom
variou
organ
system
gener
organspecif
exam
avail
better
diagnost
et
al
detect
microvascular
damag
autonom
nervou
system
heart
rate
variabl
studi
spectral
frequenc
analysi
use
ewe
batteri
cardiovascular
test
cough
reflex
sensit
ciljakova
et
al
electroderm
activ
papana
et
al
use
examin
cardiovascular
system
presenc
microangiopath
complic
electromyographi
may
use
determin
subclin
form
neuropathi
shabo
et
al
quantit
examin
sensit
function
use
determin
function
peripher
nervou
system
batteri
organspecif
exam
also
use
diagnos
autonom
neuropathi
kincaid
et
al
serum
level
age
reflect
glycosyl
hemoglobin
use
clinic
practic
recognit
diabet
microangiopathi
correl
well
glycem
control
plasma
marker
endotheli
function
von
willebrandt
factor
thrombomodulin
pselectin
may
help
recogn
endotheli
dysfunct
adegh
apart
microalbuminuria
urineblood
creatinin
blood
urea
nitrogen
measur
urin
nacetylbetadglucoseaminidas
blood
serv
earli
indic
kidney
damag
number
genespecif
polymorph
repres
patientspecif
approach
diagnosi
diabet
microangiopathi
et
al
rang
techniqu
develop
evalu
microcirculatori
function
vascular
diseas
transcutan
oxygen
tension
skin
pulp
blood
flow
iontophoresi
capillaroscopi
use
evalu
microcirculatori
function
health
diseas
abularrag
et
al
aykut
et
al
isol
small
arteri
organ
tissu
studi
mount
use
steel
wire
micromyograph
vessel
diamet
perfus
pressur
flow
measur
use
techniqu
singl
microvessel
small
microvascular
network
intern
organ
studi
intravit
microscopi
capillaroscopi
paramet
studi
vessel
diamet
flow
veloc
vessel
densiti
permeabl
leukocyt
function
appear
time
tracer
plethysmographi
use
evalu
region
blood
flow
organ
tissu
region
wherea
laser
doppler
flux
techniqu
measur
red
cell
flux
small
volum
tissu
region
skin
intern
organ
surfac
positron
emiss
tomographi
magnet
reson
imag
contrast
echocardiographi
use
investig
local
blood
flow
metabol
state
organ
struijkerboudi
et
al
direct
videomicroscop
techniqu
best
way
studi
architectur
transport
function
microvessel
romagnoli
recent
year
near
infrar
spectroscopi
emerg
promis
technolog
microcirculatori
evalu
romagnoli
avail
techniqu
bedsid
would
use
direct
intervent
therapi
optim
microcircul
evalu
microcirculatori
function
determin
clinic
end
point
vital
complic
neuropathi
remain
asymptomat
major
patient
minim
invas
laser
doppler
imag
studi
use
diagnos
patient
diabet
neuropathi
greenstein
et
al
va
rayman
corneal
confoc
microscopi
noninvas
techniqu
correl
sever
somat
neuropathi
util
measur
earli
nerv
fiber
regener
due
therapi
shtein
callaghan
noninvas
laser
dopplerbas
method
also
use
studi
microcircul
skin
presenc
peripher
autonom
diabet
neuropathi
stirban
serum
creatinin
microalbuminuria
remain
accept
end
point
diagnosi
nephropathi
assess
endotheli
dysfunct
use
variou
laser
doppler
flow
cytometri
techniqu
help
earli
diagnosi
prevent
chronic
kidney
diseas
babo
et
al
laser
speckl
contrast
imag
monitor
skin
microvascular
function
use
diagnost
tool
facilit
clinic
microvascular
studi
et
al
function
test
imag
microcircul
use
techniqu
discuss
aid
detect
subclin
neuropathi
earli
stage
nephropathi
dr
standard
classif
system
use
categor
classifi
stage
diseas
stereoscop
color
fundu
photograph
establish
adequ
therapi
wu
et
al
retin
vasculatur
allow
direct
noninvas
visual
microvasculatur
retina
brain
kidney
share
sever
anatom
featur
physiolog
properti
retin
vasculatur
chang
correl
microcircul
organ
retin
vascular
chang
use
model
studi
manifest
hypertens
includ
stroke
coronari
arteri
diseas
heart
failur
renal
diseas
global
geometr
paramet
branch
pattern
retin
vasculatur
correl
increas
mortal
cvd
develop
end
organ
damag
liew
et
al
macrovascular
microvascular
diseas
affect
two
distinct
bed
human
vasculatur
vasoregress
propos
underli
phenomenon
etiolog
patholog
thu
unifi
view
share
risk
factor
caus
pathway
process
like
common
diagnost
biomark
may
exist
carri
literatur
mine
identifi
potenti
protein
biomark
contribut
process
vasoregress
help
earli
diagnosi
condit
lipid
lipoprotein
present
chylomicron
ldl
constitut
establish
predict
measur
plasma
atherogenecitycvd
risk
well
dr
brown
bittner
kampoli
et
al
sasongko
et
al
upadhyay
inflammatori
cascad
protein
myeloperoxidas
releas
neutrophil
activ
implic
endotheli
dysfunct
myeloperoxidas
enrich
atherosclerot
lesion
high
system
level
may
serv
promis
prognost
marker
cardiovascular
event
bodi
brown
bittner
koenig
khuseyinova
elev
level
myeloperoxidas
vitreou
patient
suffer
prolif
dr
also
observ
augustin
et
al
inflammatori
creactiv
protein
crp
produc
primarili
liver
establish
strong
predict
biomark
myocardi
infarct
ischem
stroke
cardiovascular
death
incid
diabet
incid
hypertens
peripher
arteri
diseas
ridker
crp
also
involv
initi
progress
atherosclerot
lesion
activ
chemoattract
circul
monocyt
mediat
endotheli
dysfunct
induct
prothrombot
state
increas
cytokin
releas
activ
complement
system
facilit
ecm
remodel
well
lipidrel
effect
kampoli
et
al
verma
et
al
comparison
healthi
individu
found
trace
quantiti
concentr
crp
rise
exponenti
earli
hour
acut
inflammatori
condit
crp
robust
clinic
marker
due
analyt
stabil
reproduc
result
koenig
khuseyinova
higher
crp
concentr
strongli
correl
increas
number
thin
cap
fibroatheroma
koenig
khuseyinova
studi
report
associ
crp
diabet
nephropathi
dr
seddon
et
al
singl
nucleotid
polymorph
crp
shown
associ
diabet
peng
et
al
product
crp
transcript
control
certain
cytokin
like
tnfa
virani
et
al
cytokin
chemokin
biomark
also
establish
potenti
assess
clinic
resolut
ocular
inflamm
variou
clinic
studi
investig
predict
valu
plasma
concentr
futur
cardiovascular
event
kampoli
et
al
koenig
khuseyinova
possess
import
proatherogen
properti
induc
prothrombot
state
increas
express
also
report
atherosclerot
lesion
prone
ruptur
gerd
et
al
mallat
et
al
use
suggest
marker
futur
cv
event
men
requir
futur
investig
koenig
khuseyinova
significantli
high
concentr
proinflammatori
cytokin
also
associ
rheumatoid
arthriti
multipl
sclerosi
diabet
ocular
diseas
dr
gverov
et
al
kang
kim
roth
et
al
besid
credibl
cytokin
like
tnfa
potenti
ocular
inflammatori
biomark
also
establish
tnfa
particip
loss
tight
junction
ec
retina
also
cell
retin
pigment
epithelium
thu
interrupt
integr
brb
zorena
et
al
increas
level
tnfa
also
associ
variou
diseas
patholog
diabet
atherosclerosi
boesten
et
al
gustavsson
et
al
kleinbongard
et
al
particip
complement
factor
potenti
biomark
also
signifi
cvd
diseas
ross
et
al
speidl
et
al
prospect
studi
base
anim
system
establish
relationship
age
compound
ocular
diseas
patholog
like
dr
ross
et
al
stitt
et
al
util
rage
novel
biomark
also
demonstr
predict
treatment
coronari
atherosclerosi
lindsey
et
al
fibrinogen
also
regard
promis
independ
biomark
inflamm
earli
cvd
event
danesh
et
al
kampoli
et
al
also
implic
predict
certain
ocular
diseas
like
dr
use
requir
valid
azad
et
al
kuzhuppilli
increas
level
cell
adhes
molecul
also
consist
associ
atherosclerosi
ocular
diseas
like
dri
eye
diseas
ballantyn
entman
muni
et
al
elev
serum
level
growth
factor
well
demonstr
associ
atherosclerosi
dr
express
pattern
serv
earli
biomark
chow
et
al
lin
et
al
zorena
et
al
atherosclerosi
macrovascular
diseas
character
thicken
harden
arteri
besid
lifethreaten
diseas
major
caus
mortal
worldwid
may
also
involv
microvascular
complic
system
diseas
accompani
region
disturb
circul
lead
signific
sequela
brain
kidney
limb
sever
retin
constitu
pericyt
glial
cell
neuron
also
affect
system
vascular
complic
lead
disturb
crosstalk
retin
vasculatur
vasoregress
progress
demis
blood
vessel
underli
mani
diseas
respons
inflamm
character
disrupt
mc
ec
crosstalk
ultim
caus
obliter
blood
vessel
vasoregress
involv
number
physiolog
eg
vessel
format
matur
stabil
patholog
process
eg
peripher
neuropathi
diabet
nephropathi
tumor
angiogenesi
microangiopathi
mani
aspect
still
well
elucid
phenomenon
vasoregress
studi
extens
eye
initi
step
develop
vascular
oculopathi
retina
vasoregress
may
lead
brb
breakdown
result
subsequ
ocular
diseas
dr
review
briefli
list
characterist
featur
macrovascular
microvascular
diseas
drawn
parallel
featur
atherosclerosi
fig
causeeffect
sketch
illustr
probabl
factor
underli
vessel
regress
result
effect
figur
depict
probabl
caus
underli
vessel
regress
might
invok
signal
downstream
pathway
pathway
denot
red
box
found
caus
effect
enlist
red
box
box
pathway
green
box
prevent
vasculopathi
insert
vasoprotect
effect
enlist
green
box
box
apart
pathway
denot
blue
box
report
exert
diseasecaus
vasoprotect
effect
larg
vessel
vasoregress
ocular
microvasculatur
hall
mark
vasoregress
name
mc
loss
endotheli
damag
share
atherosclerosi
ocular
microangiopathi
fig
patholog
associ
common
risk
factor
increas
level
age
oxid
stress
increasemodif
circul
lipid
common
respons
inflamm
macrovascular
microvascular
diseas
includ
interleukin
pathway
leukostasi
increas
number
type
epc
increas
vascular
permeabl
glial
activ
also
provid
brief
perspect
vasoregress
molecular
scale
show
share
common
molecular
pathway
effector
atherosclerosi
ocular
diseas
dr
fig
common
pathway
share
two
diseas
immun
respons
complement
pathway
neurotrophin
pathway
pdgf
pathway
pathway
ppar
pathway
pkc
pathway
hexosamin
pathway
mapk
signal
nfjb
vegf
signal
share
pathway
may
provid
biomark
therapeut
target
diagnosi
treatment
microvascular
macrovascular
diseas
share
featur
differ
microvascular
diseas
indic
common
pathophysiolog
develop
howev
variou
microvascular
diseas
manifest
differ
clinic
symptom
due
uniqu
tissu
respons
newer
techniqu
biomark
assess
vascular
function
potenti
util
earli
detect
microvascular
diseas
common
atherosclerosi
vasoregress
shift
current
view
dr
local
condit
retina
system
inflammationinduc
vasculopathi
dr
may
attribut
vascular
chang
accompani
diabet
condit
howev
mani
aspect
vasoregress
need
elucid
eg
function
role
neuron
vessel
surviv
photoreceptor
damag
retina
yet
determin
character
differ
type
epc
involv
vasoregress
requir
role
vasoregress
vascular
patholog
occur
site
eye
still
well
elucid
express
bioavail
role
variou
pleiotrop
form
isoform
variou
signal
molecul
pkc
nfjb
vegf
differenti
cellular
effect
requir
elucid
futur
studi
unveil
issu
prove
benefici
understand
onset
human
vascular
patholog
